| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 5.19e-06 | 2 | 46 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 7.74e-05 | 6 | 46 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 1.85e-04 | 9 | 46 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.20e-04 | 129 | 46 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 3.62e-04 | 147 | 46 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.01e-04 | 151 | 46 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 5.35e-04 | 15 | 46 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.57e-04 | 465 | 46 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 6.91e-04 | 17 | 46 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 7.71e-04 | 78 | 46 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 8.30e-04 | 80 | 46 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 8.66e-04 | 19 | 46 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 8.66e-04 | 19 | 46 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | myosin V binding | 9.61e-04 | 20 | 46 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.16e-03 | 22 | 46 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.27e-03 | 23 | 46 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.27e-03 | 23 | 46 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 1.39e-03 | 24 | 46 | 2 | GO:0030742 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.44e-03 | 363 | 46 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.63e-03 | 26 | 46 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.82e-03 | 105 | 46 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.03e-03 | 29 | 46 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.31e-03 | 31 | 46 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.94e-03 | 35 | 46 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.01e-03 | 627 | 46 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | odorant binding | 3.12e-03 | 127 | 46 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 3.51e-03 | 446 | 46 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.99e-03 | 664 | 46 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | tau protein binding | 5.04e-03 | 46 | 46 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.04e-03 | 46 | 46 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.14e-03 | 303 | 46 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | helicase activity | 5.75e-03 | 158 | 46 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | channel activity | 6.95e-03 | 525 | 46 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.01e-03 | 526 | 46 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.54e-03 | 758 | 46 | 6 | GO:0015318 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.37e-06 | 259 | 45 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | amine transport | 1.19e-05 | 137 | 45 | 5 | GO:0015837 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 2.23e-05 | 264 | 45 | 6 | GO:0099504 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 2.78e-05 | 4 | 45 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 3.06e-05 | 28 | 45 | 3 | GO:0015812 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 3.41e-05 | 29 | 45 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 6.62e-05 | 321 | 45 | 6 | GO:0099003 | |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 9.71e-05 | 7 | 45 | 2 | GO:1903347 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 1.49e-04 | 233 | 45 | 5 | GO:0017157 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.58e-04 | 125 | 45 | 4 | GO:0051952 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 2.11e-04 | 53 | 45 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.51e-04 | 141 | 45 | 4 | GO:0051588 | |
| GeneOntologyBiologicalProcess | dopamine transport | 2.61e-04 | 57 | 45 | 3 | GO:0015872 | |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 2.75e-04 | 58 | 45 | 3 | GO:0061028 | |
| GeneOntologyBiologicalProcess | positive regulation of connective tissue replacement | 3.58e-04 | 13 | 45 | 2 | GO:1905205 | |
| GeneOntologyBiologicalProcess | nuclear membrane disassembly | 3.58e-04 | 13 | 45 | 2 | GO:0051081 | |
| GeneOntologyBiologicalProcess | membrane disassembly | 4.17e-04 | 14 | 45 | 2 | GO:0030397 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 4.45e-04 | 164 | 45 | 4 | GO:0007266 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 4.56e-04 | 165 | 45 | 4 | GO:1903305 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 5.38e-04 | 663 | 45 | 7 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 5.43e-04 | 664 | 45 | 7 | GO:0099177 | |
| GeneOntologyCellularComponent | CHD-type complex | 6.64e-06 | 17 | 46 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 6.64e-06 | 17 | 46 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.88e-05 | 96 | 46 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | presynapse | 1.14e-04 | 886 | 46 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | ATPase complex | 1.85e-04 | 129 | 46 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.60e-04 | 141 | 46 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.72e-04 | 155 | 46 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | axon | 6.52e-04 | 891 | 46 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | cell body | 8.57e-04 | 929 | 46 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 8.68e-04 | 85 | 46 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | axon terminus | 1.16e-03 | 210 | 46 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | terminal bouton | 1.23e-03 | 96 | 46 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | perikaryon | 1.45e-03 | 223 | 46 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | postsynapse | 1.54e-03 | 1018 | 46 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.70e-03 | 233 | 46 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.90e-03 | 405 | 46 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | distal axon | 2.59e-03 | 435 | 46 | 5 | GO:0150034 | |
| Domain | Myb_DNA-binding | 1.59e-06 | 35 | 46 | 4 | PF00249 | |
| Domain | MYB_LIKE | 2.24e-06 | 38 | 46 | 4 | PS50090 | |
| Domain | BAH | 2.28e-06 | 11 | 46 | 3 | SM00439 | |
| Domain | BAH | 2.28e-06 | 11 | 46 | 3 | PF01426 | |
| Domain | BAH_dom | 2.28e-06 | 11 | 46 | 3 | IPR001025 | |
| Domain | BAH | 2.28e-06 | 11 | 46 | 3 | PS51038 | |
| Domain | ZnF_GATA | 3.03e-06 | 12 | 46 | 3 | SM00401 | |
| Domain | ELM2 | 3.93e-06 | 13 | 46 | 3 | SM01189 | |
| Domain | ELM2 | 3.93e-06 | 13 | 46 | 3 | PF01448 | |
| Domain | ELM2 | 3.93e-06 | 13 | 46 | 3 | PS51156 | |
| Domain | ELM2_dom | 3.93e-06 | 13 | 46 | 3 | IPR000949 | |
| Domain | Rho_Binding | 5.93e-06 | 2 | 46 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 5.93e-06 | 2 | 46 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 5.93e-06 | 2 | 46 | 2 | IPR020684 | |
| Domain | Znf_GATA | 6.23e-06 | 15 | 46 | 3 | IPR000679 | |
| Domain | GATA | 6.23e-06 | 15 | 46 | 3 | PF00320 | |
| Domain | SANT | 6.83e-06 | 50 | 46 | 4 | SM00717 | |
| Domain | GATA_ZN_FINGER_1 | 7.66e-06 | 16 | 46 | 3 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 7.66e-06 | 16 | 46 | 3 | PS50114 | |
| Domain | SANT/Myb | 7.99e-06 | 52 | 46 | 4 | IPR001005 | |
| Domain | SANT_dom | 3.49e-05 | 26 | 46 | 3 | IPR017884 | |
| Domain | SANT | 4.39e-05 | 28 | 46 | 3 | PS51293 | |
| Domain | Pkinase_C | 1.02e-04 | 37 | 46 | 3 | IPR017892 | |
| Domain | Pkinase_C | 1.50e-04 | 42 | 46 | 3 | PF00433 | |
| Domain | HR1 | 1.65e-04 | 8 | 46 | 2 | PF02185 | |
| Domain | AGC-kinase_C | 3.54e-04 | 56 | 46 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.54e-04 | 56 | 46 | 3 | PS51285 | |
| Domain | S_TK_X | 3.54e-04 | 56 | 46 | 3 | SM00133 | |
| Domain | ZF_DAG_PE_1 | 5.24e-04 | 64 | 46 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.24e-04 | 64 | 46 | 3 | PS50081 | |
| Domain | C1 | 5.49e-04 | 65 | 46 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 5.74e-04 | 66 | 46 | 3 | IPR002219 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 8.85e-04 | 18 | 46 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 9.88e-04 | 19 | 46 | 2 | PS50267 | |
| Domain | SNF | 9.88e-04 | 19 | 46 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 9.88e-04 | 19 | 46 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 9.88e-04 | 19 | 46 | 2 | PS00610 | |
| Domain | Ion_trans_dom | 2.78e-03 | 114 | 46 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.78e-03 | 114 | 46 | 3 | PF00520 | |
| Domain | - | 5.77e-03 | 148 | 46 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 7.65e-03 | 164 | 46 | 3 | IPR000008 | |
| Domain | C1_1 | 8.69e-03 | 57 | 46 | 2 | PF00130 | |
| Domain | Homeodomain-like | 8.90e-03 | 332 | 46 | 4 | IPR009057 | |
| Domain | - | 9.56e-03 | 746 | 46 | 6 | 3.40.50.300 | |
| Domain | Ser/Thr_kinase_AS | 1.14e-02 | 357 | 46 | 4 | IPR008271 | |
| Domain | S_TKc | 1.16e-02 | 359 | 46 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.19e-02 | 362 | 46 | 4 | PS00108 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 9.88e-06 | 16 | 38 | 3 | M40060 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 3.62e-05 | 70 | 38 | 4 | M8232 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 5.05e-05 | 27 | 38 | 3 | MM15537 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 5.47e-05 | 154 | 38 | 5 | M39007 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 7.04e-05 | 5 | 38 | 2 | M49031 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 7.04e-05 | 5 | 38 | 2 | MM15221 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 7.71e-05 | 31 | 38 | 3 | M48258 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 1.32e-04 | 37 | 38 | 3 | M39756 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 1.77e-04 | 105 | 38 | 4 | M27425 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 2.07e-04 | 43 | 38 | 3 | M238 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY | 2.52e-04 | 9 | 38 | 2 | M47546 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 2.70e-04 | 47 | 38 | 3 | M1095 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 2.70e-04 | 47 | 38 | 3 | MM15428 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 3.83e-04 | 11 | 38 | 2 | MM15046 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.83e-04 | 11 | 38 | 2 | M47721 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.83e-04 | 11 | 38 | 2 | M47958 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 3.83e-04 | 11 | 38 | 2 | M7014 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 4.30e-04 | 55 | 38 | 3 | MM14932 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 5.42e-04 | 13 | 38 | 2 | M47547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 5.42e-04 | 13 | 38 | 2 | M47731 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 5.64e-04 | 254 | 38 | 5 | M27131 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 5.84e-04 | 61 | 38 | 3 | M27811 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 6.36e-04 | 147 | 38 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 7.03e-04 | 151 | 38 | 4 | M39329 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 7.03e-04 | 151 | 38 | 4 | M19428 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 7.27e-04 | 15 | 38 | 2 | M138 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 7.27e-04 | 15 | 38 | 2 | MM15037 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 8.29e-04 | 16 | 38 | 2 | MM15048 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 8.37e-04 | 69 | 38 | 3 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 8.73e-04 | 70 | 38 | 3 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 8.73e-04 | 70 | 38 | 3 | MM15597 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 9.38e-04 | 17 | 38 | 2 | M5488 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.03e-03 | 74 | 38 | 3 | M41807 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.05e-03 | 18 | 38 | 2 | M225 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 1.07e-03 | 75 | 38 | 3 | M27343 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 1.18e-03 | 19 | 38 | 2 | MM1361 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.18e-03 | 19 | 38 | 2 | MM1514 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.18e-03 | 19 | 38 | 2 | M3494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.18e-03 | 19 | 38 | 2 | M27493 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 1.18e-03 | 19 | 38 | 2 | M9152 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.21e-03 | 301 | 38 | 5 | MM15983 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.30e-03 | 20 | 38 | 2 | M18415 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.30e-03 | 20 | 38 | 2 | MM15485 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.30e-03 | 20 | 38 | 2 | MM1383 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.44e-03 | 21 | 38 | 2 | M27736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.44e-03 | 21 | 38 | 2 | M47767 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.58e-03 | 22 | 38 | 2 | M39795 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.73e-03 | 23 | 38 | 2 | M41817 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.88e-03 | 24 | 38 | 2 | M2243 | |
| Pathway | WP_EFFECTS_OF_MFN2_MUTATION | 1.88e-03 | 24 | 38 | 2 | M48308 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.94e-03 | 335 | 38 | 5 | MM14503 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 2.04e-03 | 25 | 38 | 2 | MM15608 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.05e-03 | 94 | 38 | 3 | M27230 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 2.24e-03 | 97 | 38 | 3 | M48262 | |
| Pathway | REACTOME_PTEN_REGULATION | 2.30e-03 | 98 | 38 | 3 | MM15348 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 2.37e-03 | 99 | 38 | 3 | MM15905 | |
| Pathway | WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY | 2.38e-03 | 27 | 38 | 2 | M39899 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.42e-03 | 211 | 38 | 4 | MM14502 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.65e-03 | 103 | 38 | 3 | MM14752 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 2.73e-03 | 104 | 38 | 3 | M39625 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.74e-03 | 29 | 38 | 2 | M27309 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.74e-03 | 29 | 38 | 2 | MM15028 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.88e-03 | 106 | 38 | 3 | M27077 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 2.96e-03 | 107 | 38 | 3 | M48260 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.13e-03 | 31 | 38 | 2 | M7223 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.20e-03 | 110 | 38 | 3 | M48259 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 3.20e-03 | 110 | 38 | 3 | M27696 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 3.54e-03 | 33 | 38 | 2 | MM1426 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.62e-03 | 115 | 38 | 3 | M9387 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 3.71e-03 | 116 | 38 | 3 | M2164 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 3.76e-03 | 34 | 38 | 2 | M3342 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 3.98e-03 | 35 | 38 | 2 | M16801 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.98e-03 | 35 | 38 | 2 | M41738 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 4.21e-03 | 36 | 38 | 2 | MM15603 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 4.44e-03 | 37 | 38 | 2 | M41813 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 4.44e-03 | 37 | 38 | 2 | MM15022 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.44e-03 | 37 | 38 | 2 | MM15683 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.67e-03 | 411 | 38 | 5 | M735 | |
| Pathway | WP_G13_SIGNALING | 4.68e-03 | 38 | 38 | 2 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 4.92e-03 | 39 | 38 | 2 | MM15898 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 5.43e-03 | 41 | 38 | 2 | M39655 | |
| Pubmed | Identification and characterization of metastasis-associated gene/protein 1 (MTA1). | 2.17e-09 | 3 | 46 | 3 | 25315816 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 26869315 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 31036553 | ||
| Pubmed | ROCK2 CACNA1A PRKCB GRIA3 ROCK1 CSNK1A1L SF3B1 BCR RAB3A RAB3B PTPRS | 3.81e-08 | 963 | 46 | 11 | 28671696 | |
| Pubmed | 1.21e-07 | 8 | 46 | 3 | 18067919 | ||
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 26028330 | ||
| Pubmed | RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. | 1.81e-07 | 9 | 46 | 3 | 22926524 | |
| Pubmed | PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex. | 2.58e-07 | 10 | 46 | 3 | 34180153 | |
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 22560079 | ||
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 20720167 | ||
| Pubmed | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. | 6.14e-07 | 13 | 46 | 3 | 19703393 | |
| Pubmed | 6.14e-07 | 13 | 46 | 3 | 12920132 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.74e-07 | 774 | 46 | 9 | 15302935 | |
| Pubmed | 7.80e-07 | 14 | 46 | 3 | 16428440 | ||
| Pubmed | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. | 7.80e-07 | 14 | 46 | 3 | 25150861 | |
| Pubmed | The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1. | 9.74e-07 | 15 | 46 | 3 | 25247294 | |
| Pubmed | NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. | 9.74e-07 | 15 | 46 | 3 | 19927129 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 35523828 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29115372 | ||
| Pubmed | Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma. | 1.71e-06 | 2 | 46 | 2 | 24617500 | |
| Pubmed | [Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells]. | 1.71e-06 | 2 | 46 | 2 | 25916120 | |
| Pubmed | Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 1.71e-06 | 2 | 46 | 2 | 23479079 | |
| Pubmed | Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. | 1.71e-06 | 2 | 46 | 2 | 19590140 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24429217 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12778124 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18495812 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26468018 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28035042 | ||
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 1.71e-06 | 2 | 46 | 2 | 22462535 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19363681 | ||
| Pubmed | Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction. | 1.71e-06 | 2 | 46 | 2 | 30165352 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32877952 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30196430 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29800294 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18668558 | ||
| Pubmed | Role of Rho-kinase in regulation of insulin action and glucose homeostasis. | 1.71e-06 | 2 | 46 | 2 | 16098829 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28709411 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32234882 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15096457 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21471517 | ||
| Pubmed | Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. | 1.71e-06 | 2 | 46 | 2 | 25840982 | |
| Pubmed | ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. | 1.71e-06 | 2 | 46 | 2 | 22934846 | |
| Pubmed | ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. | 1.71e-06 | 2 | 46 | 2 | 16098146 | |
| Pubmed | Functional role of Rho-kinase in ameloblast differentiation. | 1.71e-06 | 2 | 46 | 2 | 21792909 | |
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 1.71e-06 | 2 | 46 | 2 | 20803696 | |
| Pubmed | Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. | 1.71e-06 | 2 | 46 | 2 | 26481340 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18331468 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29211497 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30369081 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29987023 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 8772201 | ||
| Pubmed | ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. | 1.71e-06 | 2 | 46 | 2 | 19131646 | |
| Pubmed | Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. | 1.71e-06 | 2 | 46 | 2 | 31302146 | |
| Pubmed | Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. | 1.71e-06 | 2 | 46 | 2 | 23328676 | |
| Pubmed | The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. | 1.71e-06 | 2 | 46 | 2 | 18695890 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20169147 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30642362 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11856890 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24170433 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12508221 | ||
| Pubmed | ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. | 1.71e-06 | 2 | 46 | 2 | 30884801 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18695640 | ||
| Pubmed | Rho-associated kinases play a role in endocardial cell differentiation and migration. | 1.71e-06 | 2 | 46 | 2 | 15464581 | |
| Pubmed | Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. | 1.71e-06 | 2 | 46 | 2 | 23789633 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28225294 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15044207 | ||
| Pubmed | ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. | 1.71e-06 | 2 | 46 | 2 | 18414683 | |
| Pubmed | ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. | 1.71e-06 | 2 | 46 | 2 | 31914704 | |
| Pubmed | Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. | 1.71e-06 | 2 | 46 | 2 | 22348083 | |
| Pubmed | Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system. | 1.71e-06 | 2 | 46 | 2 | 25319202 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30771534 | ||
| Pubmed | Rho-associated kinase is a therapeutic target in neuroblastoma. | 1.71e-06 | 2 | 46 | 2 | 28739902 | |
| Pubmed | Matrix rigidity differentially regulates invadopodia activity through ROCK1 and ROCK2. | 1.71e-06 | 2 | 46 | 2 | 26826790 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24562870 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25934709 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29246448 | ||
| Pubmed | ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. | 1.71e-06 | 2 | 46 | 2 | 26276827 | |
| Pubmed | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. | 1.71e-06 | 2 | 46 | 2 | 28679962 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27791202 | ||
| Pubmed | ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. | 1.71e-06 | 2 | 46 | 2 | 38199985 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17167780 | ||
| Pubmed | ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders. | 1.71e-06 | 2 | 46 | 2 | 27033194 | |
| Pubmed | Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates. | 1.71e-06 | 2 | 46 | 2 | 27269648 | |
| Pubmed | Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. | 1.71e-06 | 2 | 46 | 2 | 25755711 | |
| Pubmed | Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase. | 1.71e-06 | 2 | 46 | 2 | 24289040 | |
| Pubmed | Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma. | 1.71e-06 | 2 | 46 | 2 | 33278350 | |
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. | 1.71e-06 | 2 | 46 | 2 | 23392171 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 23250919 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28923399 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17347801 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24168723 | ||
| Pubmed | Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues. | 1.71e-06 | 2 | 46 | 2 | 22986902 | |
| Pubmed | Dissecting the roles of ROCK isoforms in stress-induced cell detachment. | 1.71e-06 | 2 | 46 | 2 | 23598717 | |
| Pubmed | Activation of Rho kinase isoforms in lung endothelial cells during inflammation. | 1.71e-06 | 2 | 46 | 2 | 19201893 | |
| Pubmed | ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs. | 1.71e-06 | 2 | 46 | 2 | 29044117 | |
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. | 1.71e-06 | 2 | 46 | 2 | 19997641 | |
| Pubmed | Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells. | 1.71e-06 | 2 | 46 | 2 | 33744762 | |
| Pubmed | Role of Rho kinase isoforms in murine allergic airway responses. | 1.71e-06 | 2 | 46 | 2 | 21565918 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27203208 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22355071 | ||
| Interaction | ZBTB2 interactions | 5.08e-06 | 450 | 44 | 8 | int:ZBTB2 | |
| Interaction | FOXK2 interactions | 8.97e-06 | 225 | 44 | 6 | int:FOXK2 | |
| Interaction | MLNR interactions | 1.45e-05 | 68 | 44 | 4 | int:MLNR | |
| Interaction | H3C7 interactions | 1.93e-05 | 73 | 44 | 4 | int:H3C7 | |
| Interaction | RNU11 interactions | 3.06e-05 | 28 | 44 | 3 | int:RNU11 | |
| Interaction | ZFPM2 interactions | 3.06e-05 | 28 | 44 | 3 | int:ZFPM2 | |
| Interaction | ZNF827 interactions | 3.41e-05 | 29 | 44 | 3 | int:ZNF827 | |
| Interaction | TCF19 interactions | 4.61e-05 | 32 | 44 | 3 | int:TCF19 | |
| Interaction | KDM5B interactions | 6.65e-05 | 100 | 44 | 4 | int:KDM5B | |
| Interaction | STAG1 interactions | 7.75e-05 | 104 | 44 | 4 | int:STAG1 | |
| Interaction | MBD3L2 interactions | 9.77e-05 | 41 | 44 | 3 | int:MBD3L2 | |
| Interaction | HMG20B interactions | 1.44e-04 | 122 | 44 | 4 | int:HMG20B | |
| Interaction | NACC2 interactions | 1.57e-04 | 48 | 44 | 3 | int:NACC2 | |
| Interaction | CDK2AP2 interactions | 1.67e-04 | 49 | 44 | 3 | int:CDK2AP2 | |
| Interaction | FAM219A interactions | 1.77e-04 | 50 | 44 | 3 | int:FAM219A | |
| Interaction | LIN52 interactions | 1.88e-04 | 51 | 44 | 3 | int:LIN52 | |
| Interaction | GATA4 interactions | 2.54e-04 | 411 | 44 | 6 | int:GATA4 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.10e-06 | 12 | 32 | 3 | 1305 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.23e-06 | 53 | 32 | 4 | 532 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.26e-06 | 15 | 32 | 3 | 82 | |
| GeneFamily | Olfactory receptors, family 8 | 3.39e-03 | 49 | 32 | 2 | 155 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.67e-03 | 206 | 32 | 3 | 682 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 5.89e-03 | 65 | 32 | 2 | 388 | |
| Coexpression | GSE10325_BCELL_VS_LUPUS_BCELL_UP | 1.62e-05 | 194 | 43 | 5 | M3094 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 171 | 46 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 172 | 46 | 4 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 179 | 46 | 4 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 179 | 46 | 4 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 179 | 46 | 4 | ec7c38464863ac3744a8d4880f49421914892339 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 180 | 46 | 4 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 184 | 46 | 4 | 1e6f86f9e379cd9f453f6b7185f681b44eb63e09 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-05 | 185 | 46 | 4 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.75e-05 | 194 | 46 | 4 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 4.94e-05 | 196 | 46 | 4 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 5.14e-05 | 198 | 46 | 4 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| Drug | 6-methylenetestosterone acetate | 1.54e-07 | 6 | 46 | 3 | CID000159323 | |
| Drug | AC1L1JG6 | 2.77e-06 | 14 | 46 | 3 | CID000005026 | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.89e-06 | 199 | 46 | 6 | 3230_UP | |
| Drug | Rockout | 3.99e-06 | 2 | 46 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 3.99e-06 | 2 | 46 | 2 | CID000102394 | |
| Drug | NSC-114340 | 4.24e-06 | 16 | 46 | 3 | CID000004598 | |
| Drug | 2-aminoethyl diphenylborinate | 5.69e-06 | 127 | 46 | 5 | CID000001598 | |
| Drug | aescine | 6.54e-06 | 60 | 46 | 4 | CID004555259 | |
| Drug | AC1L1JVU | 1.36e-05 | 72 | 46 | 4 | CID000005229 | |
| Drug | nifedipine | 1.84e-05 | 415 | 46 | 7 | CID000004485 | |
| Drug | GDP-b-S | 1.86e-05 | 162 | 46 | 5 | CID000643998 | |
| Drug | Fura-2AM | 1.96e-05 | 79 | 46 | 4 | CID000105091 | |
| Drug | vanilpyruvic acid | 2.39e-05 | 4 | 46 | 2 | CID000014124 | |
| Drug | diguanosine pentaphosphate | 2.39e-05 | 4 | 46 | 2 | CID004577574 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 3.47e-05 | 308 | 46 | 6 | CID000001915 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.60e-05 | 186 | 46 | 5 | 7499_UP | |
| Drug | tetrahydrooxazine | 3.98e-05 | 5 | 46 | 2 | CID000449101 | |
| Drug | A61603 | 4.04e-05 | 33 | 46 | 3 | CID004038180 | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.09e-05 | 191 | 46 | 5 | 7486_UP | |
| Drug | AC1NSKHR | 4.42e-05 | 34 | 46 | 3 | CID005311362 | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 2313_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 3862_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 1698_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 2228_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 3930_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 2327_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 1522_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 1507_UP | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 2947_UP | |
| Drug | brazilein | 5.96e-05 | 6 | 46 | 2 | CID006453902 | |
| Drug | levormeloxifene | 5.96e-05 | 6 | 46 | 2 | ctd:C108255 | |
| Drug | AC1L1CTF | 5.96e-05 | 6 | 46 | 2 | CID000002056 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 6.70e-05 | 39 | 46 | 3 | CID000107855 | |
| Drug | dopamine | 8.25e-05 | 715 | 46 | 8 | CID000000681 | |
| Drug | 6-BME | 8.33e-05 | 7 | 46 | 2 | CID005748218 | |
| Drug | AC1L2VEC | 8.33e-05 | 7 | 46 | 2 | CID000129320 | |
| Drug | S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (3S)-3-hydroxy-3-methyl-5-oxohexanethioate | 1.11e-04 | 8 | 46 | 2 | CID016061173 | |
| Drug | GGTI-297 | 1.11e-04 | 8 | 46 | 2 | CID009956145 | |
| Drug | heptenoic acid | 1.11e-04 | 8 | 46 | 2 | CID000029373 | |
| Drug | N-palmitoyl-serine | 1.11e-04 | 8 | 46 | 2 | CID000085997 | |
| Drug | oxethazaine | 1.11e-04 | 8 | 46 | 2 | CID000004621 | |
| Drug | SC-46275 | 1.11e-04 | 8 | 46 | 2 | CID005311427 | |
| Drug | Y-26763 | 1.11e-04 | 8 | 46 | 2 | CID000121878 | |
| Drug | pimozide | 1.26e-04 | 127 | 46 | 4 | CID000016362 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 1.33e-04 | 568 | 46 | 7 | CID000000806 | |
| Drug | P6Chol | 1.42e-04 | 9 | 46 | 2 | CID000126085 | |
| Drug | GTP[S] | 1.70e-04 | 591 | 46 | 7 | CID000001764 | |
| Drug | nicardipine | 2.09e-04 | 145 | 46 | 4 | CID000004473 | |
| Drug | MCI-154 | 2.17e-04 | 11 | 46 | 2 | CID000123941 | |
| Drug | leys | 2.17e-04 | 11 | 46 | 2 | CID000484683 | |
| Drug | cytosine | 2.48e-04 | 441 | 46 | 6 | CID000000597 | |
| Drug | oxanol | 2.60e-04 | 12 | 46 | 2 | CID000136505 | |
| Drug | DMEP | 2.60e-04 | 12 | 46 | 2 | CID000008344 | |
| Drug | FeTMPyP | 2.60e-04 | 12 | 46 | 2 | CID009853416 | |
| Drug | U46619 | 2.67e-04 | 285 | 46 | 5 | CID000005618 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.49e-04 | 12 | 45 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.23e-04 | 195 | 45 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.05e-04 | 17 | 45 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | 7.75e-04 | 477 | 45 | 5 | C0005586 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 7.79e-04 | 27 | 45 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | emphysema imaging measurement | 1.45e-03 | 146 | 45 | 3 | EFO_0007626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYRMEMSIFYVVYFV | 1481 | O00555 | |
| YRAFVDNYGVAMEMA | 591 | P11274 | |
| YYFSGECQEVYMAMR | 251 | Q5VXM1 | |
| VTDGAFFDYMAVYRM | 131 | Q9UKT5 | |
| FEAAFMYVFYVMYDG | 146 | P29033 | |
| MYVFYVMYDGFSMQR | 151 | P29033 | |
| FRMYTRERFEGFMDY | 991 | Q7Z478 | |
| YMANYMEGIEGRQVY | 16 | P20711 | |
| PEMEMAYEGQYDAYR | 151 | Q9ULX6 | |
| MAANMYRVGDYVYFE | 1 | O94776 | |
| YYRGAMGFILMYDIT | 91 | P20336 | |
| YYRGAMGFILMYDIT | 91 | P20337 | |
| FYMLAAMAYDRYVAI | 111 | Q96RB7 | |
| RYCSDYGMIDDMIYF | 46 | Q9BXT6 | |
| MFGWFAMVIAYVVYY | 211 | Q9BY71 | |
| RGVYAIFGFYDQMSM | 96 | P42263 | |
| REMAFRTEMGLYYSY | 56 | Q2PZI1 | |
| LYFVMEYVNGGDLMY | 416 | P05771 | |
| RDDMESLGYVFMYFN | 201 | Q8N752 | |
| ECYMLTSMAYDRYVA | 111 | Q8NGG8 | |
| RYQYFVVDPMAEYNM | 1801 | Q13332 | |
| DMRGLFDYMCYYDVV | 236 | Q9P203 | |
| MYSFCYRVMFEAGYL | 171 | P22680 | |
| LDEDYLYMAYADIMA | 3716 | P21817 | |
| ENMVYYFLEESTGYM | 4626 | P21817 | |
| AFEFVLEYMDRMVGY | 141 | Q8IZU8 | |
| ECYMLTSMAYDRYVA | 111 | Q96RD0 | |
| MMYQQGEFYYGEFSD | 216 | Q99574 | |
| CYVPYAAFAMYMVNN | 261 | P03999 | |
| MAANMYRVGDYVYFE | 1 | Q9BTC8 | |
| MVTEGGMYVFQLFDY | 446 | P31641 | |
| NRLYDAMIYVYNRGM | 676 | Q8N3P4 | |
| MVTDGGMYVFQLFDY | 461 | P48029 | |
| MAANMYRVGDYVYFE | 1 | Q13330 | |
| DTMDAGYMDEEGYLY | 536 | Q9H6R3 | |
| GYMDEEGYLYVMSRV | 541 | Q9H6R3 | |
| VTYEPMAYMDAAYFG | 61 | P20142 | |
| LMDAEYANYYTREVM | 756 | O75533 | |
| YFARPDSMFEDQMVY | 286 | Q06203 | |
| RGEMQYMYFKAEPYA | 1026 | Q96K76 | |
| FYAFQDDRYLYMVME | 156 | O75116 | |
| MTYCMYDFDLGYVQG | 441 | Q8TC07 | |
| YAFQDDRYLYMVMEY | 141 | Q13464 | |
| LYFMSDAYMGCDQEY | 2106 | O75643 | |
| EIAGMQRFGAFYMDY | 526 | Q7Z7G8 | |
| QRFGAFYMDYLYTME | 531 | Q7Z7G8 | |
| VYYMEGRDSMQLIYR | 376 | Q5SXM2 | |
| GFDAFMTGYVMAYVE | 441 | Q96GM8 | |
| VAFMIGMFNLYSYYR | 591 | Q9HCX4 | |
| LRYQREIQGGYMDMY | 501 | O15049 |